19,372 Shares in Revvity, Inc. (NYSE:RVTY) Acquired by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. purchased a new position in shares of Revvity, Inc. (NYSE:RVTY) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 19,372 shares of the company’s stock, valued at approximately $2,117,000.

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. purchased a new position in Revvity during the 3rd quarter worth approximately $1,579,487,000. Ceredex Value Advisors LLC purchased a new position in Revvity during the 4th quarter worth approximately $108,353,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in Revvity during the 4th quarter worth approximately $33,568,000. Boston Trust Walden Corp purchased a new position in Revvity during the 4th quarter worth approximately $25,154,000. Finally, KBC Group NV purchased a new position in Revvity during the 3rd quarter worth approximately $25,301,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of Revvity stock in a transaction on Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the sale, the insider now owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.60% of the stock is currently owned by corporate insiders.

Revvity Price Performance

Shares of NYSE RVTY opened at $100.77 on Tuesday. The firm has a market cap of $12.45 billion, a PE ratio of 18.32, a PEG ratio of 2.63 and a beta of 1.09. The firm has a fifty day moving average of $104.69 and a 200 day moving average of $101.52. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.77 and a current ratio of 2.07. Revvity, Inc. has a one year low of $79.50 and a one year high of $135.67.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Thursday, February 1st. The company reported $1.25 EPS for the quarter, topping the consensus estimate of $1.15 by $0.10. The company had revenue of $695.90 million during the quarter. Revvity had a net margin of 25.20% and a return on equity of 7.41%. As a group, research analysts predict that Revvity, Inc. will post 4.65 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.28 annualized dividend and a yield of 0.28%. Revvity’s dividend payout ratio (DPR) is presently 5.09%.

Wall Street Analyst Weigh In

RVTY has been the subject of a number of recent research reports. Barclays raised their price target on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. KeyCorp lifted their target price on shares of Revvity from $110.00 to $126.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Stifel Nicolaus lifted their target price on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a report on Friday, February 2nd. Evercore ISI raised shares of Revvity from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $88.00 to $125.00 in a report on Thursday, January 4th. Finally, Raymond James lifted their target price on shares of Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $118.91.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.